| SpectraBase Spectrum ID |
B0dKJXkZqiW |
| Name |
N-Piperidino-2-(2,3-dihydroindol-3-yl)ethanamine |
| Classification |
Designer drug side product |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
230.178298716 u |
| Formula |
C15H22N2 |
| InChI |
InChI=1S/C15H22N2/c1-4-9-17(10-5-1)11-8-13-12-16-15-7-3-2-6-14(13)15/h2-3,6-7,13,16H,1,4-5,8-12H2 |
| InChIKey |
NPOWDFUKDKZAES-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
230.355 g/mol |
| Nominal Mass |
230 u |
| Quality |
947 |
| Retention Index |
2020 |
| SMILES |
C=12C(NCC2CCN2CCCCC2)=CC=CC1 |
| SPLASH |
splash10-001a-9300000000-5e19e41d68fbed94ec1d |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
3-(2-(piperidin-1-yl)ethyl)-2,3-dihydro-1H-indole |
| Technique |
GC/MS |
| Wiley ID |
DD2024_016022 |
